Apellis Pharmaceuticals - 48 Year Dividend History | APLS

Historical dividend payout and yield for Apellis Pharmaceuticals (APLS) since 1971. The current TTM dividend payout for Apellis Pharmaceuticals (APLS) as of April 18, 2019 is $0.00. The current dividend yield for Apellis Pharmaceuticals as of April 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.193B $0.000B
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Apellis Pharmaceuticals, Inc. is based in CRESTWOOD, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.312B 12.32
Gilead Sciences (GILD) United States $80.293B 10.22
Bio-Techne Corp (TECH) United States $7.144B 48.13